Top

Published in:

Open Access 01-04-2017 | Editorial Comment

Atherosclerosis should be a rare disease in the lives of children born today

Author: R. J. G. Peters

Published in: Netherlands Heart Journal | Issue 4/2017

Excerpt

The spectacular fall in cardiovascular mortality that has occurred in most western societies in the past 40 years has contributed significantly to a steady rise in life expectancy. The Royal Dutch Actuarial Association has estimated, in its ‘Projection Table 2016’, that the life expectancy of a girl born in 2016 is 93.0 years and that of a boy born in 2016 90.1 years [1]. With a touch of optimism, these projections may in fact be an underestimation, since much of the potential for prevention of cardiovascular disease is still waiting to be used. …

Projection Table AG2014 of 9 September 2014. http://www.ag-ai.nl/view/33207-ProjectionTable+AG2016.pdf. Accessed Febr. 15, 2017.

Young F, Capewell S, Ford ES, Critchley JA. Coronary mortality declines in the U.S. between 1980 and 2000 quantifying the contributions from primary and secondary prevention. Am J Prev Med. 2010;39(3):228–34.CrossRefPubMed

Vaartjes I, O’Flaherty M, Grobbee DE, Bots ML, Capewell S. Coronary heart disease mortality trends in the Netherlands 1972–2007. Heart. 2011;97:569–73.CrossRefPubMed

Hoedemaker NPG, ten Haaf ME, Maas JC, et al. Practice of ST-segment elevation myocardial infarction care in the Netherlands during four snapshot weeks with the National Cardiovascular Database Registry for Acute Coronary Syndrome. Neth Heart J. 2017; doi:10.1007/s12471-017-0947-6.PubMed

Sahlen A, Varenhorst C, Lagerqvist B, et al. Outcomes in patients treated with ticagrelor or clopidogrel after acute myocardial infarction: experiences from SWEDEHEART registry. Eur Heart J. 2016;37(44):3335–42.CrossRefPubMed

Cerit L, Duygu H, Gulsen K, Gunsel A. Effect of statins on coronary blood flow after percutaneous coronary intervention in patients with stable coronary artery disease. Neth Heart J. 2017; doi:10.1007/s12471-016-0883-x.

Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937–52.CrossRefPubMed

Minneboo M, Lachman S, Snijder MB, Vehmeijer JT, Jørstad HT, Peters RJG. Risk factor control in secondary prevention of cardiovascular disease: results from the multi-ethnic HELIUS study. Neth Heart J. 2017; doi:10.1007/s12471-017-0956-5.PubMed

Bergheanu SC, Bodde MC, Jukema JW. Pathophysiology and treatment of atherosclerosis: current view and future perspective on lipoprotein modification treatment. Neth Heart J. 2017; doi:10.1007/s12471-017-0959-2.PubMed

Title: Atherosclerosis should be a rare disease in the lives of children born today
Author: R. J. G. Peters
Publication date: 01-04-2017
Publisher: Bohn Stafleu van Loghum
Published in: Netherlands Heart Journal / Issue 4/2017
Print ISSN: 1568-5888
Electronic ISSN: 1876-6250
DOI: https://doi.org/10.1007/s12471-017-0976-1

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Atherosclerosis should be a rare disease in the lives of children born today

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2017

Mark E. Josephson (1943–2017)

Response

Unexpected rhythm regularity in a patient with atrial fibrillation and a changing frontal plane axis over time

Practice of ST-segment elevation myocardial infarction care in the Netherlands during four snapshot weeks with the National Cardiovascular Database Registry for Acute Coronary Syndrome

Risk factor control in secondary prevention of cardiovascular disease: results from the multi-ethnic HELIUS study

Bifurcation PCI: keep it safe and simple!

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page